Ablation devices maker SonaCare Medical lands a meeting to review its ultrasound-based prostate cancer ablation device with an FDA panel that just shot down similar device.
North Carolina-based SonaCare Medical is getting a day with the FDA, but the company's prospects are murky given that it's going before an advisory panel that just rejected a technology similar to SonaCare's Sonablate 450 prostate cancer therapy.
News Well, Ablation, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Prostate, Regulatory/Compliance, Urology
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/XExCH1
Cap comentari:
Publica un comentari a l'entrada